{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910452187603321"]
[null,null,"Titolo",null,"AIDS vaccines, HIV receptors, and AIDS research [[electronic resource] /] / Lawrence B. Kendow, editor"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Biomedical Books, c2008"]
[null,null,"ISBN",null,"1-60876-480-X"]
[null,null,"Descrizione fisica",null,"1 online resource (358 p.)"]
[null,null,"Disciplina",null,"615/.372"]
[null,null,"Soggetti",null,"AIDS vaccines"]
[{"$nulls":4},"HIV (Viruses)"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"AIDS VACCINES, HIV RECEPTORS,  AND AIDS RESEARCH\"\"; \"\"CONTENTS\"\"; \"\"PREFACE\"\"; \"\"Chapter 1   SAFE AND EFFECTIVE HIV VACCINES SINCE 1999       \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION\"\"; \"\"SOME PRE-1984 VACCINES FOR HUMAN USE \"\"; \"\"Plague \"\"; \"\"Variolation \"\"; \"\"Edward Jennerâ€?s Smallpox Vaccine\"\"; \"\"Louis Pasteurâ€?s Vaccines\"\"; \"\"Polio Vaccines\"\"; \"\"THE NORMAL HUMAN IMMUNE RESPONSE\"\"; \"\"THE WORST PANDEMIC IN HISTORY, HIV/AIDS\"\"; \"\"The First Announcement of the Isolation of the Causative Agent of AIDS  \"\"; \"\"The Natural History of HIV Infection in Man\"\""]
[{"$nulls":4},"\"\"Ethical Considerations in HIV Preventive Vaccine Research  \"\"\"\"THE AUTHORâ€?S APPROACH TO HIV VACCINES DEVELOPMENT\"\"; \"\"A General Surgeon Involved with HIV Vaccines Research and Development? \"\"; \"\"What is Cure of HIV Infection?\"\"; \"\"The Stepping Stone for HIV Preventive Vaccines Development\"\"; \"\"Not all Medical Remedies Require Registration before use on Patients\"\"; \"\"Possible Appropriate Immunogens for a Candidate HIV Therapeutic Vaccine\"\"; \"\"Confirmation of the Safety of the Candidate Autogenous HIV Therapeutic Vaccine\"\"; \"\"Efficacy Trials of the Safe Candidate HIV Therapeutic Vaccine\"\""]
[{"$nulls":4},"\"\"Proceeding to the HIV Preventive Vaccine \"\"\"\"Modifications to the Initial Vaccines and Dosage Regimen\"\"; \"\"THE VACCINES ON LARGER POPULATIONS\"\"; \"\"VEHEMENT RESISTANCE TO ATTEMPTS TO LOCK UP OUR HIV VACCINES\"\"; \"\"CONCLUSION\"\"; \"\"APPENDICES\"\"; \"\"REFERENCES \"\"; \"\"Chapter 2   AIDS: A MUCOSAL APPROACH TO A MUCOSAL INFECTION  \"\"; \"\"ABSTRACT\"\"; \"\"INTRODUCTION\"\"; \"\"Mucosal "]
[{"$nulls":4},"Transmission and HIV Receptors\"\"; \"\"Correlates of Protection;  LTNPs, Elite Controllers and Natural Hosts \"\"; \"\"TARGETING THE MUCOSAL IMMUNE SYSTEM\"\"; \"\"Mucosal Adjuvants \"\"; \"\"Innate Immunity and Antiviral Factors \"\""]
[{"$nulls":4},"\"\"Early Experiments Revisited â€? Xeno and Allo-Immunity in HIV Protection \"\"\"\"SUMMARY \"\"; \"\"REFERENCES\"\"; \"\"Chapter 3   TRANSMISSION OF HIV FROM DENDRITIC CELLS TO CD4+ T CELLS:  A PROMISING TARGET FOR VACCINATION AND THERAPEUTIC INTERVENTION \"\"; \"\"ABSTRACT \"\"; \"\"INTRODUCTION \"\"; \"\"1. Subsets of DCs and Susceptibility to HIV Infection\"\"; \"\"2. Restriction of HIV-1 Replication in DCs\"\"; \"\"3. HIV Transmission from DC to T cells: trans vs. cis Infection\"\"; \"\"4. How to Achieve Immune Protection: Future Directions \"\"; \"\"CONCLUSION \"\"; \"\"ACKNOWLEDGEMENTS \"\"; \"\"REFERENCES \"\""]
[{"$nulls":4},"\"\"Chapter 4   THE GLOBALIZATION-AIDS-POVERTY SYNDROME IN AFRICA1  \"\"\"\"INTRODUCTION \"\"; \"\"NEOLIBERALIZM AND AIDS IN CONTEXT \"\"; \"\"COLONIALISM, GENDER, AND THE GEOGRAPHY OF HIV\"\"; \"\"THE LIBERALIZATION OF AIDS: GLOBALIZATION AND POVERTY\"\"; \"\"MAKING THE LINKS: GENDER, DEEPENING POVERTY  AND AIDS\"\"; \"\"BREAKING THE GAPS\"\"; \"\"REFERENCES \"\"; \"\"Chapter 5   YOUTH SEXUALITY IN THE CONTEXT OF HIV/AIDS IN SOUTH AFRICA  \"\"; \"\"ABSTRACT\"\"; \"\"1. INTRODUCTION \"\"; \"\"Socialization\"\"; \"\"Sexual Relations\"\"; \"\"Sexuality Research and HIV\"\"; \"\"Culture and Sexuality\"\"; \"\"Sociohistorical Context \"\"; \"\"2. METHODOLOGY\"\""]
[{"$nulls":4},"\"\"Sample and Procedure\"\""]